QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients
QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic t…
FAULHABER receives Dräger „Production and Innovation Award“
"This award confirms our claims that we are a reliable partner to our customers, particularly when it comes to planning…
TranzX PST 09 at Eurobike
TranzX Power Support Technology 09, JD Group's next-generation pedal-activated drive system for electric bicycles, will…
